Ventilation Defect Formation in Healthy and Asthma Subjects Is Determined by Lung Inflation by Harris, Robert Scott et al.
 
Ventilation Defect Formation in Healthy and Asthma Subjects Is
Determined by Lung Inflation
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Harris, R. Scott, Hanae Fujii-Rios, Tilo Winkler, Guido Musch,
Marcos F. Vidal Melo, and José G. Venegas. 2012. Ventilation
defect formation in healthy and asthma subjects is determined by
lung inflation. PLoS ONE 7(12): e53216.
Published Version doi:10.1371/journal.pone.0053216
Accessed February 19, 2015 11:57:48 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11235954
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAAVentilation Defect Formation in Healthy and Asthma





2, Marcos F. Vidal Melo
2, Jose ´ G. Venegas
2
1Department of Medicine (Pulmonary and Critical Care Unit), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of
America, 2Anesthesia and Critical Care, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
Abstract
Background: Imaging studies have demonstrated that ventilation during bronchoconstriction in subjects with asthma is
patchy with large ventilation defective areas (Vdefs). Based on a theoretical model, we postulated that during
bronchoconstriction, as smooth muscle force activation increases, a patchy distribution of ventilation should emerge, even
in the presence of minimal heterogeneity the lung. We therefore theorized that in normal lungs, Vdefs should also emerge in
regions of the lung with reduced expansion.
Objective: We studied 12 healthy subjects to evaluate whether Vdefs formed during bronchoconstriction, and compared
their Vdefs with those observed in 9 subjects with mild asthma.
Methods: Spirometry, low frequency (0.15 Hz) lung elastance and resistance, and regional ventilation by intravenous
13NN-
saline positron emission tomography were measured before and after a challenge with nebulized methacholine. Vdefs were
defined as regions with elevated residual
13NN after a period of washout. The average location, ventilation, volume, and
fractional gas content of the Vdefs, relative to those of the rest of the lung, were calculated for both groups.
Results: Consistent with the predictions of the theoretical model, both healthy subjects and those with asthma developed
Vdefs. These Vdefs tended to form in regions that, at baseline, had a lower degree of lung inflation and, in healthy subjects,
tended to occur in more dependent locations than in subjects with asthma.
Conclusion: The formation of Vdefs is determined by the state of inflation prior to bronchoconstriction.
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Introduction
Using different imaging techniques, ventilation defective regions
(Vdefs) have been demonstrated in asymptomatic asthma subjects
[1] and after inhalation of methacholine [2–5] or after exercise
[5,6]. Positron-emission tomography (PET) dynamic imaging
studies of intravenously injected
13NN-saline showed the develop-
ment of Vdefs during acute bronchoconstriction consistent with
severely hypoventilating units clustered in relatively large,
contiguous regions of the lung [3,4,7]. In a previous study of
asthma subjects [3], we found that the ventilation defects tended to
be located towards the dependent regions of the lung regardless of
whether the same subject was imaged supine or prone, and
attributed that to a vertical gradient of lung inflation. In addition,
we found that in the prone position, where the subject’s lungs had
a greater state of inflation, Vdefs tended to be smaller than in the
supine position [3]. Those results were consistent with a theoretical
model of bronchoconstriction that includes dynamic inter-depen-
dence among parenchymal forces, gas pressures and airways in a
tree structure [7]. The model also predicts that, for a given smooth
muscle activation, a reduction in forces on the airway wall, due to
less expanded parenchyma, should result in the emergence of
Vdefs, and these should increase in size with further reductions in
lung inflation [8].
Despite the fact that Vdefs tended to form in dependent regions
of the lung, they did not form exclusively there [4]. This, it was
speculated, could be because of other factors in the airways of
asthma subjects such as inflammation, edema, and local smooth
muscle hyperresponsiveness may predispose specific regions to
become Vdefs. These considerations led us to question whether in
subjects without asthma, Vdefs could form under bronchoconstric-
tive challenge and, if so, to wonder where the Vdefs would be
located. Although Vdefs have been demonstrated widely in asthma
subjects, they have not been previously shown to occur in healthy
subjects challenged with methacholine. In this study, we sought to
test whether Vdefs are formed in healthy subjects and compare
their location with those seen in asthma subjects. Specifically, since
healthy subject’s airways would be less likely to have airway
inflammation, edema or remodeling and thus have only the
regional influence of lung inflation in Vdef formation, we tested
whether in healthy subjects after a bronchoconstrictive stimulus,
PLOS ONE | www.plosone.org 1 December 2012 | Volume 7 | Issue 12 | e53216Vdefs should be even more likely to form in more dependent zones
compared to asthma subjects.
Methods
Ethics statement
The protocol, procedures, consent form and consent process
were reviewed and approved by the Human Research Committee
of the Massachusetts General Hospital. Before participation,
written informed consent was obtained from all subjects.
Subject characteristics
Nine subjects with mild asthma and twelve healthy subjects
were studied. Baseline characteristics are given in Table 1. Nine
subjects with mild asthma and twelve healthy subjects were
studied. The subjects were recruited by advertisements posted in
the hospital and through general e-mail announcements within the
Partners Heathcare System. Subjects with mild asthma were
considered eligible if they had been diagnosed with asthma, were
over age 18, had not had an upper respiratory infection in the last
month prior to screening, had not been smoking for the 3 months
prior to screening and had less than a 10 pack-year smoking
history. Subjects with asthma were questioned to determine if their
asthma met the National Asthma Education and Prevention
Program’s definition for mild to moderate asthma [9]. Healthy
subjects were considered eligible if they were over 18, had not
been smoking for the 3 months prior to screening and had less
than a 10 pack-year smoking history, had normal PFT results, had
a PC20 dose .8 mg/ml, and had not had an upper respiratory
infection in the last month prior to screening. Both subjects with
asthma and healthy subjects were excluded if they were a member
of the study staff, had other lung diseases or heart disease, were
pregnant, or had been exposed to more than half of the expected
radiation dose for the protocol in the past year (3.75 mSv).
Subjects with asthma were also excluded if they had a history of
being unresponsive to albuterol, had taken oral steroids in the past
year for subjects with asthma, or had an absolute contraindication
for methacholine challenge testing (FEV1,50% predicted or
,1 L, heart attack or stroke in the last 3 months, uncontrolled
hypertension, or known aortic aneurysm).
Study protocol
The study protocol consisted of one screening and one imaging
session. If the subject had not had a standard methacholine (MCh)
challenge test within the past year, one was conducted during the
screening session in the seated position at least one week before the
imaging session. If subjects were taking asthma medications, these
were stopped prior to MCh challenge testing and imaging
according to MCh challenge guidelines.
2 The provocative
concentration (Provocholine, Methapharm, Coral Springs, FL,
USA) that caused a 20% fall in FEV1 (PC20) was determined for
all subjects up to a maximum dose of 25 mg/mL. Subjects with a
PC20 dose #8 mg/mL and a past medical history of asthma were
considered subjects with asthma while those with PC20 dose
.8 mg/mL without any past medical history of asthma were
considered as healthy subjects. Subjects who did not meet these
criteria were excluded. On the study day, before any study
procedures all subjects had spirometry, plethysmographic lung
volumes and diffusing capacity measured in the upright position to
verify that they did not have obstruction or restriction and to
confirm that the DLCO was in the normal range. Subjects were
then positioned supine in the PET scanner, with their arms outside
the scanner resting on armrests, and remained in that position for
the rest of the study, including during MCh inhalation. The
imaging field was selected to include the bases of the lung above
the diaphragm to maximize the volume of lung within the 10 cm
long field of view of the PET scanner. Lung volume changes were
monitored continuously by impedance plethysmography (Som-
noStar PT, SensorMedics Corp., Yorba Linda, CA, USA) and the
signal continuously displayed to the subject on a computer screen.
Oscillatory mechanics were measured as previously described [10–
12] and the low frequency (0.15 Hz), resistance (Rlow) and
elastance (Elow) were derived. After acquiring a 10-minute
transmission scan and baseline oscillatory mechanics, the subject
was instructed to take two deep breaths. During the exhalation
phase of the second breath, the subject was instructed to stop
breathing at lung volume equal to the mean lung volume
previously estimated from the impedance plethysmographic signal
during steady state breathing. At the start of apnea, a bolus of
13NN-saline (,30 ml) was injected intravenously (5 ml/s) and
dynamic acquisition of sequential emission scans was initiated [3].
After 30 to 40 s of apnea the subject was instructed to resume
breathing while coached to match his/her previous rate and tidal
volume as displayed on the computer screen. At the end of a 3-
minute washout period, spirometry was performed in the same
position using a hand-held portable spirometer (Satellite Spirom-
eter, Jones Medical Instrument Co., Oak Brook, IL, USA). While
supine with the head turned to the side, five breaths of
methacholine were then administered to the subject at his/her
previously determined PC20 dose or up to a maximum of 25 mg/
mL for healthy controls via a DeVilbiss nebulizer (model 646,
DeVilbiss Heathcare Company, Somerset, PA, USA). An identical
imaging sequence and data collection to that acquired in baseline
conditions was repeated starting five minutes after administration
of the methacholine. Post-bronchoconstriction measurements were
finished within 20 minutes to ensure being done between the peak
and end of plateau phase of MCh action [13].
Data analysis
For baseline and during bronchoconstriction, images displaying
the topographic distribution of
13NN tracer retention were
generated from the activity remaining in the lung at the end of
the 3-minute washout period. Using the tracer retention image
taken during bronchoconstriction, a Vdef region of interest (ROI)
was defined by selecting a set of voxels containing more than 20%
of the highest tracer concentration on that image. The threshold
value was a trade-off between obtaining a region large enough to
reduce the effect of noise and small enough to include only areas of
significant tracer retention. Little change in the size of the Vdefs
was seen when the value for thresholding was varied in the vicinity
of 20%. Once the Vdefs ROI was defined, all voxels outside of this
region, but within the lung mask, defined better ventilated areas
outside of Vdefs (Out). The fraction of lung occupied by Vdefs was
calculated by dividing the number of voxels within the Vdefs ROI
by the total number of voxels in the lung mask (FVdef).
The specific ventilation (alveolar ventilation per unit volume,
s _ V VA) within Vdefs was calculated from the washout kinetics of the
average ROI
13NN concentration and expressed as a ratio of the
s _ V VA of the rest of the imaged lung ( _ V VVdef=Out). The heterogeneity
of the voxel-by-voxel s _ V VA distribution for the imaged lung was
characterized by the mean-normalized variance of the tracer
washout rate [cov2 s _ V VA =(SD/mean)
2]. Regional fractional gas
content (Fgas), defined as the volume fraction of gas contained in a
lung region, was calculated for each ROI from the transmission
scans [4]. Average Fgas for the entire imaged lung, the vertical
gradient in Fgas, and the relative Fgas (FgasVdef/Out)o fVdefs regions
in relation to that of the rest of the lung were also calculated. The
Vdef Formation during Bronchoconstriction
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calculated as the distance between the geometric center of the lung
mask (GCLung) and that of the Vdefs (GCVdefs) in the left-to-right and
dorso-ventral directions (Figure 1). The deviations between the
GCLung and GCVdefs were normalized by the corresponding width
(right-left) and height (ventral-dorsal) with the positive sign
assigned to the right and ventral directions.
Because of the limited sample size of the study, the non-
parametric Wilcoxon two sample rank sum test was used to assess
significance comparing before and after methacholine at a level of
p,0.05 and analysis was performed using STATISTICA
(StatSoft, Inc.; Tulsa, OK). Data are expressed as mean 6 SD.
Linear regression was performed on plots of Fgas versus height
using MATLAB (The Mathworks, Natick, MA).
Results
In the upright position, healthy subjects and subjects with mild
asthma had normal pulmonary function test results measured at
baseline (Table 2). In that position, the methacholine dose to the
asthmatic subjects was selected such that FEV1, was reduced by
20% (PC20=1.2361.24 mg/mL). Also, in the erect position, by
protocol, the maximum methacholine dose given to the normal
subjects (25 mg/mL), reduced FEV1 by less than 20%. These
results contrast with those measured in the supine position the day
of the study: FEV1 decreased by almost 40% in asthma subjects
versus 25% in healthy subjects (p,0.05) both much greater than
the reductions seen in the erect position (Table 2). Consistent with
the greater degree of FEV1 drop during the methacholine
challenge, Rlow increased significantly more in asthma subjects
than in healthy subjects. Elow after methacholine was reduced in
both groups but there was no difference in the percent drop
between the two groups in (Table 2).
Formation of ventilation defects
After the methacholine challenge Vdefs formed in both groups,
and with similar degrees of hypoventilation relative to the rest of
the lung
The specific ventilation of Vdefs was less than half of that of the
rest of the lung (Table 2), and this was not different between both
groups. Similarly, the fraction if the imaged volume of lung
occupied by Vdefs for both subject groups was not different
(Table 2).
The global heterogeneity in ventilation (measured as the
coefficient of variation of specific ventilation) increased in both
groups during the methacholine challenge but there was no
Table 1. Subject Characteristics.
Subjects Age (yr) Gender BMI (kg/m
2) Height (in) Weight (lb) PC20 (mg/mL)
Healthy
h041 42 M 23.5 73 178 .25
h044 55 F 29.2 63 165 .25
h045 20 M 26.6 69 180 .25
h046 64 F 29.2 64 170 .25
h047 55 F 28.9 63 163 .25
h050 34 F 24.5 64 143 .25
h052 39 M 24.3 73 184 .25
h053 23 F 33.5 64 195 .25
h056 24 F 22.7 62.5 126 .25
h057 56 M 27.7 70 193 .25
h058 49 F 19.9 63.75 115 .25
h064 24 F 22.7 62 124 .25
average 40.4 26.1 66.0 161.3
sd 15.4 3.8 4.2 27.8
Subjects Age (yr) Gender BMI (kg/m
2) Height (in) Weight (lb) PC20 (mg/mL)
Asthma
h029 43 M 30 75 240 2.50
h031 56 F 36.9 68 243 3.46
h032 22 F 26.3 62.5 146 0.38
h034 27 F 17.1 67 109 2.40
h035 31 F 23.6 61.5 127 0.24
h036 24 M 24.2 65 145 1.25
h038 39 M 30.3 70 211 0.25
h043 50 F 23.9 66 148 0.34
h054 40 M 30.8 70 215 0.25
average 36.9 27.1 67.2 176.0 1.23
sd 11.8 5.7 4.2 51.1 1.24
doi:10.1371/journal.pone.0053216.t001
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baseline or during bronchoconstriction.
Before the challenge, the regions that later became Vdefs had an
average specific ventilation that was not different to that of the rest
of the lung. In other words, the Vdefs and the rest of the lung had
similar specific ventilation at baseline. In both healthy subjects and
subjects with asthma, Vdefs were formed generally, but not always,
in the most dependent (dorsal) regions of the lung (Figure 1). In
average, the geometric center of the Vdefs was vertically more
dependent than the geometric center of the imaged lung, (p,0.05)
in both of the groups. However, the healthy subjects had, on
average, a more dependent deviation of the Vdefs (p,0.05, Figure 1
and Figure 2). In the horizontal (right to left) direction, in average
there were not systematic deviations between the geometric
centers of the Vdefs and the lung.
Mean and regional lung inflation
Both groups experienced a similar average increase in Fgas of
7% during bronchoconstriction with the magnitude of the increase
negatively related with the baseline mean Fgas (Figure 3 and
Table 2). Before bronchoconstriction, the ratio in Fgas within areas
that became ventilation defects over that of the rest of the lung
(FgasVdef/Out) was in average less than unity (p,0.05) in both
healthy subjects and subjects with asthma (Figure 4). This means
that at baseline the areas that after challenge became Vdefs were
less expanded than the rest of the lung. In addition, mean FgasVdef/
Out at baseline was significantly lower (p,0.05) in healthy subjects
compared to that in subjects with asthma. Thus, compared with
the rest of the lung, parenchymal expansion at baseline of areas
that bacame Vdefs after challenge was lower in the healthy than in
asthma subjects (Table 2 and Figure 4). During bronchoconstric-
tion there was no difference in mean FgasVdef/Out between groups
(Table 2 and Figure 4), indicating that once the Vdefs were formed,
the contrast in lung expansion between Vdefs and is the rest of the
lung was similar in asthma and healthy subjects.
Vertical gradient
At baseline, there were systematic vertical gradients in Fgas such
that Fgas increased with the height above the lower surface of the
imaged lung (gradient of Fgas .0, p,0.05). Also, there was no
Figure 1. Analysis of geometric center of the lungs (GCLung)
and ventilation defects (GCVdef). The left column shows projections
of Vdefs (in red) for healthy subjects and the right column for subject
with mild asthma. The white cross represents the GCLung and the
orange cross is the GCVdef. There are three views of the lung in each
image (clockwise from top left): transverse viewed caudo-cranially,
sagittal, and coronal. In these images, Vdefs that deviate toward the
bottom of the page result in negative distances between GCLung and




Baseline BC % Change Baseline BC % Change
FEV1 (L) 2.7460.89 2.0560.80 225.1614.6 2.6460.45 1.6260.36 238.767.23*
FVC (L) 3.1861.00 2.5160.95 221.2612.8 3.0260.58 2.0660.60 233.168.91*
Rlow 5.4361.00 92.0654.7 173061250 5.8762.58 1776103 330062090*
Elow 6.2761.90 10.164.00 61.6637.3 8.8563.00 17.2611.8 82.3674.0
Mean Lung Fgas 0.6560.06 0.6960.04 7.7965.38 0.6460.04 0.6960.04 7.3365.24
Fgas Vdef/Out 0.9460.04
{ 1.0060.02 6.9464.98 0.9860.03*
{ 1.0360.05 5.8764.86
Fgas gradient 0.006960.0033 0.000460.0020 290.0638.0 0.006860.0033 0.000460.0039 2105651.8
_ V VVdef=Out 1.1460.14
{ 0.4460.15
{ 261.0616.3 1.0460.14 0.5460.16
{ 246.0625.0
cov2 s _ V VA 0.5760.08 0.9460.25 65.26200 0.6160.19 1.0560.24 71.2624.7
F Vdef 0.3460.11 0.3460.14
Values are means 6 SD. Rlow, low-frequency resistance; Elow, low-frequency elastance; Fgas, fractional gas content; Vdef, ventilation defect; _ V VVdef=Out, specific
ventilation inside Vdefs vs. outside; cov2 s _ V VA, coefficient of variation of specific ventilation; FVdef, fraction of total imaged volume occupied by Vdefs. % change refers to
the change during bronchoconstriction compared to baseline. *P,0.05 compared to Healthy.
{P,0.05 compared to ratio of 1.
doi:10.1371/journal.pone.0053216.t002
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and Figure 5). During bronchoconstriction, both groups demon-
strated a reduction in Fgas gradient, which was reduced from
0.006960.003 cm
21 to 0.000460.002 cm
21 in healthy subjects,
and from 0.006860.0034 cm
21 to 0.000460.0039 cm
21 in
subjects with asthma. Thus, during bronchoconstriction the
average Fgas gradient of both groups was no longer greater than
zero. It follows that the 0.07 increase in mean Fgas following
methacholine challenge, and the loss of the vertical gradient were
largely driven by a regional increase in Fgas in the most dependent
lung (Figure 6).
Discussion
This study demonstrated that, as in asthma subjects, large
ventilation defects do form in healthy subjects after inhalation of
methacholine. Although by protocol, the dose of the agonist given
to healthy subjects reduced FEV1 less than 20% when tested in
erect position; when measured during scanning in the supine
position the reduction of FEV1 was in average 25%. Both in
healthy and asthma subjects the Vdefs tended to develop in
dependent and less expanded areas (lower Fgas) of the lung.
Healthy subjects do not differ from asthma subjects in this regard,
except that Vdefs of healthy subjects were more dependent than
those in asthma subjects. Given that both asthma and healthy
subjects demonstrated vertical gradients in lung inflation (Figure 5
and Figure 6), taken together these results imply that for healthy
subjects, the Vdefs are favored to form in regions of reduced lung
inflation prior to agonist inhalation, whereas in asthma subjects,
the formation of Vdefs may be affected by other factors that are not
necessarily localized in dependent regions of the lung.
Before discussing the significance of these results, it is important
to note some limitations of this study. The general experimental
limitations of the PET imaging technique have been discussed in
previous reports [3,4,14–16]. Among others they include the
limited spatial resolution of PET, the fact that the tracer is
delivered by perfusion into distal regions, and the need to study the
subject in the recumbent positions. The relatively low spatial
resolution prevents the visualization and direct quantification of
ventilation and Fgas heterogeneities within regions ,,1c m
3. This
limits the volume at which Vdefs can be detected and reduced the
contrast in specific ventilation between Vdefs and the rest of the
lung. However, given the inherent patchiness of bronchoconstric-
tion [7] observed both in animals [17,18] and humans [4], the
limited spatial resolution should not invalidate the main result of
this paper: that Vdefs also form in healthy supine subjects and that
these tend to develop in the dependent and less distended regions
of the lung.
The delivery of the
13NN tracer intravenously implies that the
intrapulmonary distribution of the tracer before the washout is
proportional to by perfusion. Thus, if the Vdefs received less
perfusion than the rest of the lung, as we have previously observed
[4], regions of severe vasoconstriction could have been excluded
from Vdefs. However, in spite of the reduced initial tracer
concentration in Vdefs, at the end of the washout period the
activity remaining was much higher that that in the rest of the
Figure 2. Plots of Geometric Centers in subjects with asthma
vs. healthy subjects. A. The ventral deviation of calculated geometric
center of ventilation defects (GCVdef) from the geometric center of the
lungs (GCLung). Both healthy subjects and subjects with asthma
demonstrated a vertical dependence in Vdefs. However healthy subjects
have a significantly (P=.028) lower ventral deviation compared to that
of subjects with asthma. B. The horizontal (x-axis) deviation of
calculated geometric center of ventilation defects (GCVdef) from the
geometric center of the lungs (GCLung). (p.0.05).
doi:10.1371/journal.pone.0053216.g002
Figure 3. Plot of change in fractional gas content (Fgas)i n
healthy subjects and subjects after bronchoconstriction versus
baseline Fgas. Mean Lung Fgas increased after bronchoconstriction
for both healthy subjects and subjects with asthma. Subjects that
initially had a lower baseline mean lung Fgas had a larger increase in
mean lung Fgas during bronchoconstriction when compared to those
that started off with a higher baseline mean lung Fgas.
doi:10.1371/journal.pone.0053216.g003
Figure 4. FgasVdef/Out in basline and bronchcoconstriction (BC)
conditions for healthy subjects and subjects with asthma. At
baseline, Fgas values are below 1 for most healthy subjects and subjects
with asthma. After bronchoconstriction, the Fgas was much more
heterogeneous, with values both above and below 1.
doi:10.1371/journal.pone.0053216.g004
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the elevated resistance of peripheral airways, the
13NN method
can be more sensitive detecting regions of severe hypoventilation
than methods delivering a tracer by inhalation.
Finally, it is unclear whether Vdefs would form in healthy erect
subjects following methacholine inhalation. For obvious regions
this study was limited to imaging subjects in the recumbent
position. This has two consequences: 1) the reduction in functional
residual capacity of the supine compared with the erect position
was probably responsible for the exaggerated obstruction by
methacholine inhalation and additional reduction in FEV1 [19],
and 2) in addition to the effect of gravity on the lung parenchyma
and mediastinal structures, the position and shape of the
diaphragm [20] was likely responsible for the reduced lung
inflation of the dependent regions that potentiated the formation
of Vdefs.
We limited the study to subjects with mild asthma, in which
other factors such as airway remodeling, inflammation and mucus
are likely to be small or absent. These factors may have greater
importance in affecting the formation of Vdefs as the severity of
Figure 5. Fractional gas content (Fgas) gradients in healthy controls and subjects with asthma at baseline and during
bronchoconstriction. The grayscale of the squares in the plots corresponds to the number of data points with that value such that the darker the
square, the greater the number of points with that value. The linear regression line (solid black) is shown and the number at the top of each line is the
gradient (610
23/cm) for each plot.
doi:10.1371/journal.pone.0053216.g005
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difference in methacholine dose given to subjects. The asthma
subjects received their respective PC20 doses, but healthy subjects
were only challenged with the maximum recommended dose for
methacholine challenge tests (25 mg/mL). This means that
although healthy subjects actually received the highest doses of
methacholine, based on the functional (FEV1) change, they were
less constricted than the subjects with asthma. Thus from this
study we cannot rule out that if the bronchoconstrictive stimulus
was matched in both groups the difference in vertical dependence
of Vdefs would disappear. However, we found that plotting the Vdef
location versus change in FEV1 did not show any correlation
between strength of constriction and vertical location of Vdefs for
Figure 6. Height above the lung versus gas fraction (Fgas) at baseline (solid line) and during bronchoconstriction (dotted line).
Except for h056 and h058 in the healthy control group and h032 and h034 in the asthma group, the observed increase in mean lung Fgas was mostly
due to an increase in Fgas in the most dependent lung.
doi:10.1371/journal.pone.0053216.g006
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to those of the asthma subjects (Figure 7).
Ventilation defective regions have been demonstrated in asthma
subjects after methacholine using PET [3,4,7] or MRI [1,2,21],
after exercise [5] and in stable patients with asthma [22] using
hyperpolarized gas magnetic resonance imaging (MRI). Our
group previously reported a nearly equal vertical dependence of
Vdef formation in asthma subjects regardless of position, either
prone or supine [3]. The ventral deviation of Vdefs in those asthma
subjects studied in the supine position was slightly less than in the
present study (20.12 versus 20.17), which may be a result of the
methacholine being given in the prone position, where the aerosol
could have been distributed more homogeneously.
Although Vdefs formed preferentially in dependent regions of the
lung for both groups (Figure 2), in healthy subjects, the vertical
deviation of Vdefs was more pronounced compared with that of
subjects with asthma. In addition, at baseline FgasVdef/Out was less
than unity in both groups but significantly lower in healthy
subjects compared to that of subjects with asthma. The
observation of a baseline FgasVdef/Out lower than unity is consistent
with a previous study where in 9 out of 11 subjects with mild
asthma had a baseline FgasVdef/Out,1 [4]. Furthermore, healthy
subjects demonstrate clear vertical gradients in Fgas, with Fgas
decreasing in the dorsal to ventral direction (Figure 5). Taken
together, these findings support the notion that in healthy subjects
a small difference of parenchymal distending forces in the supine
position was enough to drive the formation of ventilation defects in
dependent zones.
Ventilation defective regions in subjects with asthma, while still
having a tendency to form in dependent zones, had less vertical
deviation toward dependent regions when compared to that of
healthy subjects (Table 2 and Figure 2). Also, subjects with asthma
had slightly greater FgasVdef/Out compared to that of healthy
subjects but yet had similar baseline and bronchoconstriction Fgas
gradients as those of healthy subjects. These results suggest that the
reduced vertical dependence of Vdef formation in subjects
compared to that of healthy subjects was not due to differences
in local lung inflation but may have been related to other factors
that could precipitate the formation of Vdefs. Examples of such
factors may include differences in airway wall thickness (smooth
muscle hyperplasia, edema and/or inflammation), smooth muscle
contractile strength (hyperresponsiveness), airway mucus, or
uncoupling between airway wall and parenchyma reducing local
parenchymal tethering forces [3]. Another factor potentially
affecting the location of Vdefs in the asthma subjects could have
been a heterogeneous deposition of the methacholine aerosol due
to heterogeneous ventilation, which would have been affected by
the factors previously described.
We found an increase in lung mean Fgas and of imaged lung field
volume as a result of the methacholine challenge for healthy and
asthma subjects. These increases are similar to those measured for
supine subjects in previous studies [3,4]. What is notable in this
studyisthat,despitea greaterdegreeofglobalobstructioncausedby
the methacholine challenge in the asthma subjects (higher Rlow and
lower FEV1), both groups had similar increases in lung volume and
similar sized Vdefs, which are consistent with the lack of difference of
the change in Elow between the two groups. In addition, a relative
increase in regional expansion of the ventilation defective regions
(FgasVdef/out increased in all regions) was detected during broncho-
constriction. As in previously studies [3,4], the relatively greater
increase in Fgas observed in Vdefs compared with the rest of the lung
may be caused by either a relative reduction in local blood volume
or to dynamic hyperinflation of these regions.
There are several potential clinical implications of these findings.
It is known that the supine position results in greater bronchial
hyperresponsiveness compared with the erect position [19] and a
many patients with asthma often exhibit increased symptoms at
night [23]. We have shown previously [3] that reduced lung volume
in the supine position compared with prone during bronchocon-
striction results in larger Vdefs for the same dose of MCh. Indeed,
studies using nocturnal continuous positive airway pressure in
asthma have shown improved nocturnal asthma symptoms [24],
quality of life [25] and airway hyperresponsiveness [26].
In conclusion, in healthy subjects and very mild asthma, the
formation of Vdefs depends on the state of regional lung inflation
prior to inhalation of agonist. What is remarkable is how such a
small difference in parenchymal distension at baseline can
predispose the formation of Vdefs. This finding, however, is
consistent with the theoretical predictions of model of the lung that
included short and long distance dynamic interactions between
airway pressure, parenchymal forces and the airway smooth
muscle. In that model, a reduction in lung volume decreases the
critical level of smooth muscle constriction needed to trigger Vdef
formation [7]. Thus, in the presence of elevated smooth muscle
activity, even a small local reduction in lung volume can be
sufficient to trigger the emergence of a Vdef. In more severe
asthma, it can be expected that other factors may be more
important in triggering the formation of Vdefs, such as airway
inflammation, smooth muscle hypertrophy, or airway edema.
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